Related references
Note: Only part of the references are listed.Effects of norepinephrine and 2 receptor antagonist ICI 118,551 on whisker hair follicle mechanoreceptors dissatisfy Merkel discs being adrenergic synapses
Mayumi Sonekatsu et al.
MOLECULAR BRAIN (2019)
Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease
Matthew J. Shepard et al.
JOURNAL OF NEUROSURGERY (2019)
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
Beatriz Gonzalez-Rodriguez et al.
BMJ OPEN OPHTHALMOLOGY (2019)
β-adrenergic Receptor Blocker ICI 118,551 Selectively Increases Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa)-Mediated Relaxations in Rat Main Mesenteric Artery
Melike Hacer Ozkan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype
Yung-Chiang Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Propranolol for Off-label Treatment of Patients With Melanoma Results From a Cohort Study
Vincenzo De Giorgi et al.
JAMA ONCOLOGY (2018)
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial
Eric Jonasch et al.
LANCET ONCOLOGY (2018)
The first prospective trial for von Hippel-Lindau disease: pazopanib
Rachel H. Giles et al.
LANCET ONCOLOGY (2018)
In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines
David Rincon-Fernandez et al.
CARCINOGENESIS (2018)
Isolation, identification, and characterization of cancer stem cells: A review
Mohammad Reza Abbaszadegan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
Virginia Albinana et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
Chao Zhang et al.
ONCOTARGET (2017)
2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells
Hongyu Chen et al.
CANCER SCIENCE (2017)
Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
Naikhoba C. O. Munabi et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Short-term effects of β2-AR blocker ICI 118,551 on sarcoplasmic reticulum SERCA2a and cardiac function of rats with heart failure
Haibin Gong et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
C. Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antiproliferative effects of β-blockers on human colorectal cancer cells
M. Coelho et al.
ONCOLOGY REPORTS (2015)
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients
Virginia Albinana et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
β-Adrenoceptor-Mediated Relaxation of Carbachol-Pre-Contracted Mouse Detrusor
Stefan Propping et al.
UROLOGIA INTERNATIONALIS (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
β-adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling
Fatemeh Sharifpanah et al.
CELL AND TISSUE RESEARCH (2014)
Hemangioblastomas in the elderly: Epidemiology and clinical characteristics
Charles D. Kassardjian et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms
Alexander O. Vortmeyer et al.
ACTA NEUROPATHOLOGICA (2013)
Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system
Jody Filippo Capitanio et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis
T. Shan et al.
CURRENT MOLECULAR MEDICINE (2013)
Renal cancer in von Hippel-Lindau disease and related syndromes
Birke Bausch et al.
NATURE REVIEWS NEPHROLOGY (2013)
Von Hippel-Lindau: How a rare disease illuminates cancer biology
Stephane Richard et al.
SEMINARS IN CANCER BIOLOGY (2013)
Von Hippel-Lindau Disease: A Genetic and Clinical Review
Nour Maya N. Haddad et al.
SEMINARS IN OPHTHALMOLOGY (2013)
Systemic VHL gene functions and the VHL disease
Hannah L. Bader et al.
FEBS LETTERS (2012)
von Hippel-Lindau disease: A clinical and scientific review
Eamonn R. Maher et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Antiangiogenic effects of β2-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy
Davide - Martini et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Functional and Transcriptional Induction of Aquaporin-1 Gene by Hypoxia; Analysis of Promoter and Role of Hif-1α
Irene Abreu-Rodriguez et al.
PLOS ONE (2011)
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations
I. Sanchez-Carpintero et al.
ACTAS DERMO-SIFILIOGRAFICAS (2011)
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
C. H. Storch et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Correlation between the expression of aquaporin 1 and hypoxia-inducible factor 1 in breast cancer tissues
Tiejun Yin et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation
Helen Pui Shan Wong et al.
TOXICOLOGICAL SCIENCES (2007)
β2 adrenergic antagonist inhibits cerebral cortical oxygen delivery after severe haemodilution in rats
G. M. T. Hare et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Antihypertensive drug use and the risk of prostate cancer (Canada)
L Perron et al.
CANCER CAUSES & CONTROL (2004)
Agonist and inverse agonist actions of β-blockers at the human β2-adrenoceptor provide evidence for agonist-directed signaling
JG Baker et al.
MOLECULAR PHARMACOLOGY (2003)
Treatment of intramedullary hemangioblastomas, with special attention to von Hippel-Lindau disease
V Van Velthoven et al.
NEUROSURGERY (2003)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
Nicotine-induced NO-mediated increase in cortical cerebral blood flow is blocked by β2-adrenoceptor antagonists in the anesthetized rats
S Uchida et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system
S Gläsker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand
RM Moresco et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
